ATE247474T1 - Verwendung von inosittriphosphat zur herstellung von arzneimitteln - Google Patents
Verwendung von inosittriphosphat zur herstellung von arzneimittelnInfo
- Publication number
- ATE247474T1 ATE247474T1 AT95942373T AT95942373T ATE247474T1 AT E247474 T1 ATE247474 T1 AT E247474T1 AT 95942373 T AT95942373 T AT 95942373T AT 95942373 T AT95942373 T AT 95942373T AT E247474 T1 ATE247474 T1 AT E247474T1
- Authority
- AT
- Austria
- Prior art keywords
- inosite
- triphosphate
- medicinal products
- producing medicinal
- producing
- Prior art date
Links
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 title 1
- 235000011178 triphosphate Nutrition 0.000 title 1
- 239000001226 triphosphate Substances 0.000 title 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 title 1
- MMWCIQZXVOZEGG-UHFFFAOYSA-N 1,4,5-IP3 Natural products OC1C(O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(O)C1OP(O)(O)=O MMWCIQZXVOZEGG-UHFFFAOYSA-N 0.000 abstract 2
- MMWCIQZXVOZEGG-XJTPDSDZSA-N D-myo-Inositol 1,4,5-trisphosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O MMWCIQZXVOZEGG-XJTPDSDZSA-N 0.000 abstract 2
- 230000002001 anti-metastasis Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9404568A SE9404568L (sv) | 1994-12-30 | 1994-12-30 | Användning av inositoltrisfosfat för beredning av läkemedel |
| PCT/SE1995/001585 WO1996020715A1 (en) | 1994-12-30 | 1995-12-22 | The use of inositoltrisphosphate for the preparing of medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247474T1 true ATE247474T1 (de) | 2003-09-15 |
Family
ID=20396521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95942373T ATE247474T1 (de) | 1994-12-30 | 1995-12-22 | Verwendung von inosittriphosphat zur herstellung von arzneimitteln |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0794786B1 (de) |
| JP (1) | JPH10511677A (de) |
| AT (1) | ATE247474T1 (de) |
| AU (1) | AU4361996A (de) |
| DE (1) | DE69531554T2 (de) |
| SE (1) | SE9404568L (de) |
| WO (1) | WO1996020715A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003049774A1 (en) * | 2001-12-13 | 2003-06-19 | Vital Health Sciences Pty Ltd | Transdermal transport of compounds |
| AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
| US9168216B2 (en) | 2005-06-17 | 2015-10-27 | Vital Health Sciences Pty. Ltd. | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
| WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
| WO2012122586A1 (en) | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3336583A1 (de) * | 1983-09-26 | 1985-04-25 | Udo Dr. 8400 Regensburg Ehrenfeld | Erzeugnis zur diagnose und therapie von malignen tumoren |
| US4952396A (en) * | 1986-11-19 | 1990-08-28 | Linus Pauling Institute Of Science & Medicine | Method of using phytic acid for inhibiting tumor growth |
-
1994
- 1994-12-30 SE SE9404568A patent/SE9404568L/ not_active Application Discontinuation
-
1995
- 1995-12-22 DE DE69531554T patent/DE69531554T2/de not_active Expired - Fee Related
- 1995-12-22 WO PCT/SE1995/001585 patent/WO1996020715A1/en not_active Ceased
- 1995-12-22 JP JP8520899A patent/JPH10511677A/ja active Pending
- 1995-12-22 AU AU43619/96A patent/AU4361996A/en not_active Abandoned
- 1995-12-22 AT AT95942373T patent/ATE247474T1/de not_active IP Right Cessation
- 1995-12-22 EP EP95942373A patent/EP0794786B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69531554D1 (de) | 2003-09-25 |
| SE9404568L (sv) | 1996-07-01 |
| EP0794786A1 (de) | 1997-09-17 |
| AU4361996A (en) | 1996-07-24 |
| EP0794786B1 (de) | 2003-08-20 |
| JPH10511677A (ja) | 1998-11-10 |
| WO1996020715A1 (en) | 1996-07-11 |
| SE9404568D0 (sv) | 1994-12-30 |
| DE69531554T2 (de) | 2004-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE116848T1 (de) | Verwendung von baclofen zur herstellung von arzneimitteln zur behandlung von angina pectoris. | |
| DE3684190D1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
| DE3772429D1 (de) | Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten. | |
| ATE218350T1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
| NO971568L (no) | Analoger av keratinocyttvekstfaktor | |
| DE69113386D1 (de) | Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern. | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| DE69423179D1 (de) | Prozess zur Herstellung von optisch aktiven 2-Amino-1-phenylethanol Derivaten | |
| DE68924714D1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
| ATE191849T1 (de) | Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst | |
| ATE82127T1 (de) | N-acetylglucosamin-zubereitungen zur buccalen anwendung. | |
| DE3583220D1 (de) | Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten. | |
| DE59003144D1 (de) | Destillationsanlage zur Herstellung von Wasserstoff-Peroxid. | |
| ATE196738T1 (de) | Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände | |
| ATE107168T1 (de) | Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression. | |
| DE69531554D1 (de) | Verwendung von inosittriphosphat zur herstellung von arzneimitteln | |
| ATE79254T1 (de) | Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen. | |
| ATE240116T1 (de) | Verwendung von human-beta-interferon zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von chronischer myeloidleukämie | |
| DE69432124D1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
| DE68905657D1 (de) | Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. | |
| DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
| DE69610045D1 (de) | Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE139696T1 (de) | Verwendung von benzothiazepinen zur herstellung von arzneimitteln zur behandlung von epileptischen anfällen | |
| DE59805897D1 (de) | VERWENDUNG VON HUMANEM alpha 1-SAUREN GLYCOPROTEIN ZUR HERSTELLUNG EINER PHARMAZEUTISCHEN PRÄPARATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |